Psyllium: Blood Sugar and Diabetes

Table of Contents

1. In Short
2. Why a Gel Slows Sugar
3. The 19-Trial Meta-Analysis
4. Trials in People With Diabetes
5. Psyllium Compared With Other Fibres
6. Inside a Small Trial
7. Weight, Fullness and Appetite
8. Diabetes Medicines and Timing
9. Limits of the Evidence
10. Key Research Papers
11. Connections

In Short

• Fasting blood sugar, HbA1c and insulin resistance: significantly lower than placebo in a 2024 meta-analysis of 19 trials (962 adults); fasting insulin not significantly changed.
• Dose: the HbA1c effect was not significant at doses below 10 g a day.
• In diabetes: a 2020 meta-analysis of 8 trials (395 people) reported lower fasting blood sugar, HbA1c, LDL and triglycerides, but no change in weight or BMI, and very high heterogeneity.
• Among fibres: beta-glucans and psyllium ranked first for fasting insulin and insulin resistance in a 2023 network meta-analysis, but galactomannans ranked first for HbA1c and fasting glucose.
• Medicines: the EMA monograph states that people with diabetes take it under medical supervision because diabetes treatment may need adjusting.

Why a Gel Slows Sugar

The 2017 review of fibre physics by McRorie and McKeown makes one point very clearly: the effect of a soluble fibre on blood sugar depends on its viscosity. High-viscosity gel-forming fibres (psyllium, beta-glucan, raw guar gum) improve glycaemic control in trials; non-viscous soluble fibres such as inulin, fructo-oligosaccharides and wheat dextrin, and insoluble fibres such as wheat bran, do not.

A 2023 review from authors at a psyllium-product manufacturer describes the same mechanism in plain terms: in the small intestine, psyllium gel increases the viscosity of the partly digested food, “slowing the degradation and absorption of nutrients”. Sugar arrives in the blood more gradually, so the peak after a meal is lower.

Two consequences follow. First, timing matters in principle: a gel has to be present in the gut alongside the meal to slow it, which is why many trials gave psyllium just before or with meals. Second, “fibre” is not one thing. A product labelled high-fibre that uses a non-gelling fibre would not be expected to act this way. The Dietary Fiber page covers the different types.

The 19-Trial Meta-Analysis

The largest recent pooled analysis is Gholami, Clark and Paknahad's GRADE-assessed review in BMC Endocrine Disorders (2024). It searched three major databases up to July 2022 for randomised controlled trials of psyllium in adults that measured HbA1c, fasting blood sugar, insulin or HOMA-IR.

• Trials and people: 19 trials, 962 participants.
• Fasting blood sugar: weighted mean difference −6.89 (95% CI −10.62 to −3.16), significant.
• HbA1c: −0.75 (−1.21 to −0.29), significant.
• HOMA-IR (an index of insulin resistance): −1.17 (−2.11 to −0.23), significant.
• Fasting insulin: −2.08, not statistically significant.

The subgroup analyses add useful detail. The fasting-sugar effect differed between doses below and above 10 g a day, and was not significant in trials shorter than 50 days. The HbA1c effect was not significant at doses below 10 g a day. Dose made no clear difference to insulin or HOMA-IR. In short, the trials that used more psyllium for longer are where the benefit shows up.

The abstract does not state the units for the fasting-sugar figure. HbA1c is usually reported in percentage points, and the Hemoglobin A1C page explains what a change of that size means.

Trials in People With Diabetes

Xiao and colleagues (2020) restricted their meta-analysis to people with diabetes and also looked at weight and lipids. They found 8 studies with 9 study arms and 395 participants.

• Significantly lower after psyllium: triglycerides, LDL cholesterol, fasting blood sugar and HbA1c.
• No significant change: HDL cholesterol, total cholesterol, body mass index and weight.
• Heterogeneity: I² values of 97–99% for the main outcomes.

That last line matters. An I² near 100% means almost all of the variation between trials reflects real differences between them — in dose, duration, the people studied, or how the trials were run — rather than chance. The direction of the effect is consistent; the pooled size of it is best read as approximate. The site's Type 2 Diabetes page covers the condition itself.

Psyllium Compared With Other Fibres

A Hungarian group (Juhász and colleagues, 2023) asked a different question: among all the soluble fibres tested in type 2 diabetes, which work best? Their network meta-analysis combined 46 randomised trials with 2,685 patients receiving 16 types of fibre, and ranked them using a statistic called SUCRA.

• HbA1c and fasting glucose: galactomannans ranked first.
• Fasting insulin and HOMA-IR: beta-glucans and psyllium were the most effective, with psyllium's SUCRA reported at 96.67%.
• LDL and triglycerides: galactomannans ranked first.
• Certainty: most comparisons were low or moderate.

Galactomannans are the gel-forming fibres found in guar gum and fenugreek seed. The broad message is consistent with the fibre-physics review: the fibres that perform best are the viscous, gel-forming ones, and psyllium is among them rather than uniquely ahead of them.

Inside a Small Trial

Meta-analyses can hide how small and simple many of the underlying studies are. One example is an Italian study of 40 people with type 2 diabetes who were already taking sulfonylurea tablets and following a controlled diet. They were assigned in sequence (not randomly) to 2 months of psyllium or to diet alone.

• Body mass index, waist size, HbA1c and fasting glucose fell significantly in both groups.
• After-meal lipoprotein profiles did not differ between groups.
• Triglycerides fell significantly in the psyllium group but not in the diet-only group.

Read on its own, this study does not show that psyllium improved blood sugar beyond diet, because both groups improved. It is a reminder that diet is often the active comparison in this research, and that individual trials are small enough for chance to matter — which is exactly why the pooled analyses above carry more weight than any one of them.

Weight, Fullness and Appetite

Because weight affects blood sugar, psyllium's effect on appetite and weight has been studied alongside its glycaemic effect.

• Appetite: two short randomised, double-blind crossover trials found that psyllium taken before breakfast and lunch reduced hunger and desire to eat and increased fullness between meals compared with placebo. Doses of 6.8 g and 10.2 g did better than 3.4 g. Most adverse events were mild gut symptoms, similar to placebo. These trials were run by a psyllium-product manufacturer.
• Weight (industry-authored): a 2023 meta-analysis of 6 trials (354 overweight or obese adults) reported 2.1 kg lower weight, 0.8 lower BMI and 2.2 cm smaller waist with psyllium taken just before meals (mean 10.8 g a day for 4.8 months). Its authors were employees of a psyllium-product manufacturer.
• Weight (independent): a 2023 network meta-analysis of 111 trials of 18 supplements gave psyllium a mean difference of −3.70 kg with moderate certainty, and concluded that supplements in general produce “a small weight loss”.
• In diabetes specifically: the 2020 meta-analysis found no significant change in weight or BMI.

The site's Fiber and Weight Loss page puts these figures alongside other fibres.

Diabetes Medicines and Timing

The European Medicines Agency's monograph on ispaghula husk includes two statements relevant to people with diabetes (EMA):

• Diabetic patients take ispaghula husk only under medical supervision, “because adjustment of anti-diabetic therapy may be necessary”.
• The product is taken at least half an hour to an hour before or after other medicines, because it can delay the absorption of medicines taken at the same time.

Both follow from the mechanism. A fibre that slows the absorption of sugar can, in principle, add to the effect of glucose-lowering medicines; and a gel that slows absorption of food can also slow absorption of a tablet swallowed with it. The monograph does not report specific hypoglycaemia cases; it states the precaution. More on medicine timing is in Psyllium: Allergy, Choking and Drug Timing.

Limits of the Evidence

• Heterogeneity: very high in the diabetes meta-analysis; the size of the effect varies a lot from trial to trial.
• Dose and duration: benefits for HbA1c were confined to 10 g a day or more; short trials (under 50 days) did not show a significant fasting-sugar effect.
• Surrogate outcomes: the trials measured blood tests, not diabetes complications such as kidney, eye or nerve damage.
• Industry involvement: some of the weight and appetite research was authored by employees of a psyllium-product manufacturer; the main glucose meta-analyses (2020, 2023, 2024) list university and hospital affiliations.
• Not unique: other viscous fibres perform similarly or better on some measures.

Information about how supplements interact with a specific diabetes treatment plan belongs with the prescribing clinician.

Key Research Papers

1. Gholami Z, Clark CCT, Paknahad Z. The effect of psyllium on fasting blood sugar, HbA1c, HOMA IR, and insulin control: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials. BMC endocrine disorders. 2024;24(1):82. — 19 trials, 962 adults; fasting blood sugar, HbA1c and HOMA-IR lower; insulin unchanged; dose-dependent. PubMed PMID: 38844885
2. Xiao Z, Chen H, Zhang Y, et al. The effect of psyllium consumption on weight, body mass index, lipid profile, and glucose metabolism in diabetic patients: A systematic review and dose-response meta-analysis of randomized controlled trials. Phytotherapy research : PTR. 2020;34(6):1237-1247. — 8 trials, 395 people with diabetes; glucose, HbA1c, LDL and triglycerides lower; weight unchanged. PubMed PMID: 31919936
3. Juhász AE, Greff D, Teutsch B, et al. Galactomannans are the most effective soluble dietary fibers in type 2 diabetes: a systematic review and network meta-analysis. The American journal of clinical nutrition. 2023;117(2):266-277. — 46 trials, 16 fibres; galactomannans first for HbA1c; psyllium and beta-glucans first for insulin measures. PubMed PMID: 36811560
4. Sartore G, Reitano R, Barison A, et al. The effects of psyllium on lipoproteins in type II diabetic patients. European journal of clinical nutrition. 2009;63(10):1269-71. — 40 people with type 2 diabetes; both groups improved; triglycerides fell only with psyllium. PubMed PMID: 19623196
5. McRorie JW Jr, McKeown NM. Understanding the Physics of Functional Fibers in the Gastrointestinal Tract: An Evidence-Based Approach to Resolving Enduring Misconceptions about Insoluble and Soluble Fiber. Journal of the Academy of Nutrition and Dietetics. 2017;117(2):251-264. — glycaemic benefits track fibre viscosity. PubMed PMID: 27863994
6. Gibb RD, Sloan KJ, McRorie JW Jr. Psyllium is a natural nonfermented gel-forming fiber that is effective for weight loss: A comprehensive review and meta-analysis. Journal of the American Association of Nurse Practitioners. 2023;35(8):468-476. — 6 trials; 2.1 kg weight difference; manufacturer-employed authors. PubMed PMID: 37163454
7. Brum JM, Gibb RD, Peters JC, et al. Satiety effects of psyllium in healthy volunteers. Appetite. 2016;105:27-36. — two crossover trials; psyllium before meals reduced hunger; manufacturer-run. PubMed PMID: 27166077
8. Shahinfar H, Jayedi A, Torabynasab K, et al. Comparative effects of nutraceuticals on body weight in adults with overweight or obesity: A systematic review and network meta-analysis of 111 randomized clinical trials. Pharmacological research. 2023;196:106944. — 111 trials of 18 supplements; psyllium −3.70 kg, moderate certainty. PubMed PMID: 37778464
9. Jovanovski E, Yashpal S, Komishon A, et al. Effect of psyllium (Plantago ovata) fiber on LDL cholesterol and alternative lipid targets, non-HDL cholesterol and apolipoprotein B: a systematic review and meta-analysis of randomized controlled trials. The American journal of clinical nutrition. 2018;108(5):922-932. — the companion lipid meta-analysis: 28 trials, LDL −0.33 mmol/L. PubMed PMID: 30239559
10. Slavin J. Fiber and prebiotics: mechanisms and health benefits. Nutrients. 2013;5(4):1417-35. — review of fibre and prebiotic mechanisms; psyllium among fibres with prebiotic effects. PubMed PMID: 23609775

PubMed Topic Searches

1. Psyllium and HbA1c
2. Psyllium and postprandial glucose
3. Psyllium in type 2 diabetes trials
4. Viscous fibre and glycaemic control

Back to Table of Contents

Connections

• Psyllium (Plantago ovata) — the main page
• Psyllium: Benefits Deep Dive — the evidence hub
• Cholesterol and Heart Health — the companion metabolic article
• IBS, Constipation and Diarrhoea — the gut uses
• Allergy, Choking and Drug Timing — medicine timing in detail
• Digestive and Gut Herbs — the category
• Type 2 Diabetes — the condition
• Metabolic Syndrome — blood sugar, weight and lipids together
• Hemoglobin A1C — the three-month blood sugar test
• Blood Sugar — diet approaches to glucose control
• Fiber and Weight Loss — fibre and appetite
• Chia Seeds: Soluble Fiber and Blood Sugar — another gel-forming seed
• Flaxseed: Fibre and Blood Sugar — a mucilage-rich seed
• Berberine: Blood Sugar — a plant compound studied for glucose
• Dietary Fiber — why viscous fibres differ

Back to Table of Contents